Eva Karamitopoulou

7PUBLICATIONS
15CO-AUTHORS
Innate immunityPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2024
Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer.

Eva Karamitopoulou, Anna S Wenning, Animesh Acharjee

|Jan 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.

L Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott

|Mar 25, 2022
Molecular Pathology of Pancreatic Cancer.

Eva Karamitopoulou

|Sep 16, 2021
PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgroups.

Eva Karamitopoulou, Andreas Andreou, Aurélie Pahud de Mortanges

|Dec 17, 2020
Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study.

Eva Karamitopoulou, Irene Esposito, Inti Zlobec

Pageof 2